GI360 Complete x1 day

Overview

GI360 Complete x 1 Day offers an extensive overview of gastrointestinal wellbeing by incorporating multiple analytical techniques such as advanced PCR, culture methods, biochemical testing, and microscopy. This combined approach examines elements related to digestion, microbial communities, inflammatory processes, and the presence of various microorganisms to provide a thorough perspective on gut function. Such analysis enriches understanding of the complex interactions within the digestive tract and supports exploration of gut health-related factors.

This evaluation is designed to reveal insights into microbial diversity and balance by assessing bacterial groups, marker substances, microbial enzymes, yeast, and other components involved in digestive processes. By presenting detailed information on the composition and activity of gut microbiota alongside biochemical data, the test contributes to a better grasp of individual digestive wellness and microbiome status. The assessment includes comparative patterns derived from a broad reference population to offer contextual information regarding microbial shifts and ecosystem stability.

The GI360 Complete x 1 Day test integrates diverse laboratory methods into a unified report, facilitating a holistic view of gastrointestinal condition. It combines the strengths of culture, molecular analysis, microscopic inspection, and biochemical evaluation to summarise features relevant to digestion, microbial environment, immune responses, and parasitology. This multifaceted approach supports those interested in advancing their knowledge of gut ecosystem dynamics and personal wellness.

GI360 Complete x 1 Day is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. GI360 Complete x 1 Day is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.